Relief of symptoms associated with allergic rhinitis and urticaria.
Composition:
1 tabl contains 5 mg desloratadine.
Action:
Contraindications:
Hypersensitivity to des loratadine, loratadine or any of the excipients.
Precautions:
Pregnancy and lactation:
It is not recommended during pregnancy (no safety is established). In animal studies, desloratadine was not teratogenic. Desloratadine is excreted in breast milk - breast-feeding is not recommended.
Side effects:
The most common symptoms were fatigue, dry mouth and headaches. Very rare: hallucinations, dizziness, drowsiness, insomnia, psychomotor agitation, convulsions, tachycardia, palpitations, abdominal pain, nausea, vomiting, indigestion, diarrhea, increased liver enzymes, increased bilirubin, hepatitis, muscle pain, hypersensitivity reactions (ie: anaphylaxis, angioneurotic edema, dyspnoea, pruritus, rash and urticaria).
Dosage:
Orally. Adults and adolescents (aged 12 and over): 1 tabl. once a day, with or without a meal. There are insufficient data on the efficacy of desloratadine in adolescents aged 12-17. Periodic allergic rhinitis (symptoms occur less than 4 days per week or less than 4 weeks) should be treated taking into account the patient's medical history. Treatment should be discontinued after symptoms have resolved and resumed at the time they recur. In chronic allergic rhinitis (symptoms occur for 4 days or more per week and longer than 4 weeks), the patient may be advised to continue treatment during the period of exposure to the allergen.
(C)
